Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000798682 | SCV000938308 | uncertain significance | Combined immunodeficiency due to LRBA deficiency | 2021-09-02 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine with alanine at codon 1969 of the LRBA protein (p.Gly1969Ala). The glycine residue is weakly conserved and there is a small physicochemical difference between glycine and alanine. This variant is present in population databases (rs745608560, ExAC 0.006%). This missense change has been observed in individual(s) with LRBA-related conditions (Invitae). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mendelics | RCV000798682 | SCV001136777 | likely pathogenic | Combined immunodeficiency due to LRBA deficiency | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000998304 | SCV001154293 | uncertain significance | not provided | 2018-10-01 | criteria provided, single submitter | clinical testing | |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002252239 | SCV002522845 | uncertain significance | See cases | 2021-10-13 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PM2 |